Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK

BACKGROUND: Although radiotherapy has improved local control in esophageal squamous cell carcinoma (ESCC), a considerable number of patients still experience relapse due to resistance. In this study, we aimed to evaluate the effects of cetuximab on radiosensitivity in two ESCC cell lines (ECA109 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Guifang, Feng, Liwen, Ye, Ting, Liu, Yanshen, Fan, Li, Ye, Chengzhi, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396788/
https://www.ncbi.nlm.nih.gov/pubmed/37337933
http://dx.doi.org/10.1111/1759-7714.14995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396788/
https://www.ncbi.nlm.nih.gov/pubmed/37337933
http://dx.doi.org/10.1111/1759-7714.14995

Ejemplares similares